In turn, primary care experts called for a PET scan, CT scan and biopsy. Results then showed he had a “very aggressive” form ...

"Full House" star Dave Coulier, 65, has been diagnosed with stage 3 non-Hodgkin lymphoma, the actor revealed in an exclusive ...

Dave Coulier has been diagnosed with Stage 3 non-Hodgkin lymphoma. The Full House alum shared the news on TODAY on Wednesday, ...

Recent news reveals Full House star Dave Coulier is battling stage 3 lymphoma, drawing attention and concern from fans ...

Dave Coulier was shocked to learn he has stage 3 non-Hodgkin lymphoma. He opens up to PEOPLE exclusively about his diagnosis and how he has been leaning on family and humor through his cancer journey.

Incyte’s previously disclosed phase 3 win in relapsed or refract | In the phase 3 inMIND study, Monjuvi—added to Bristol ...

CARGO Therapeutics, Inc. (CRGX) has received a new Buy rating, initiated by William Blair analyst, Sami Corwin.Don't Miss our Black Friday ...

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). | French ...

Actor Dave Coulier, known for playing Uncle Joey on the TV series Full House, announced he has stage 3 non-Hodgkin's lymphoma ...

Adcendo joins a growing group of biotechs working to usher the next generation of antibody-drug conjugates to the market.

shares new insights into the global clinical trial landscape for Diffuse Large B-Cell Lymphoma (DLBCL), further reinforcing its leadership in oncology research. This press release features multimedia.

Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add-on to Standard-of-care Induction and Maintenance Regimens ...